Literature DB >> 36187312

BioGlue cerebral embolism following acute type A aortic dissection repair.

Manabu Yamasaki1, Kohei Abe1, Ryota Nakamura1, Rihito Tamaki1, Hiroyasu Misumi1.   

Abstract

Surgical outcomes of acute Stanford type A aortic dissection (ATAAD) have significantly improved in recent decades due to advances in surgical techniques and adhesives such as BioGlue (Cryolife, Kennesaw, GA, USA). However, this convenient material can sometimes cause complications such as thrombotic embolism and pseudoaneurysm. Herein, we present the case of a 61-year-old man with ATAAD who successfully underwent total arch replacement. Five days after surgery, he collapsed due to right-sided hemiplegia. We immediately performed cerebral thrombectomy to remove thrombotic embolism caused by BioGlue, which was used to obliterate the false lumen of the dissected aorta during ATAAD repair. Learning objective: Thanks to surgical techniques and adhesives such as BioGlue, surgical outcomes of acute Stanford type A aortic dissection have significantly improved recently. However, thromboembolic events due to adhesives such as BioGlue use can happen not only during surgery, but also a few days after it.
© 2022 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved. All rights reserved.

Entities:  

Keywords:  Aortic dissection; BioGlue; Stroke

Year:  2022        PMID: 36187312      PMCID: PMC9508621          DOI: 10.1016/j.jccase.2022.07.001

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  8 in total

1.  Fatal right ventricular infarction caused by Bioglue coronary embolism.

Authors:  Zahid Mahmood; Debbie S Cook; Heyman Luckraz; Peter O'Keefe
Journal:  J Thorac Cardiovasc Surg       Date:  2004-11       Impact factor: 5.209

2.  The threat of adhesive embolization: BioGlue leaks through needle holes in aortic tissue and prosthetic grafts.

Authors:  Scott A LeMaire; Stacey A Carter; Taehee Won; Xinwen Wang; Lori D Conklin; Joseph S Coselli
Journal:  Ann Thorac Surg       Date:  2005-07       Impact factor: 4.330

3.  Complications of Bioglue postsurgery for aortic dissections and aortic valve replacement.

Authors:  Adriana Luk; Tirone E David; Jagdish Butany
Journal:  J Clin Pathol       Date:  2012-08-07       Impact factor: 3.411

4.  The Impact of Pre-Operative Malperfusion on Outcome in Acute Type A Aortic Dissection: Results From the GERAADA Registry.

Authors:  Martin Czerny; Florian Schoenhoff; Christian Etz; Lars Englberger; Nawid Khaladj; Andreas Zierer; Ernst Weigang; Isabell Hoffmann; Maria Blettner; Thierry P Carrel
Journal:  J Am Coll Cardiol       Date:  2015-06-23       Impact factor: 24.094

5.  Analysis of risk factors for neurological dysfunction in patients with acute aortic dissection type A: data from the German Registry for Acute Aortic Dissection type A (GERAADA).

Authors:  Lars Oliver Conzelmann; Isabell Hoffmann; Maria Blettner; Klaus Kallenbach; Matthias Karck; Otto Dapunt; Michael A Borger; Ernst Weigang
Journal:  Eur J Cardiothorac Surg       Date:  2012-03-01       Impact factor: 4.191

6.  Embolization of biologic glue during repair of aortic dissection.

Authors:  T Carrel; M Maurer; T Tkebuchava; U Niederhäuser; J Schneider; M I Turina
Journal:  Ann Thorac Surg       Date:  1995-10       Impact factor: 4.330

7.  Patient trends and outcomes of surgery for type A acute aortic dissection in Japan: an analysis of more than 10 000 patients from the Japan Cardiovascular Surgery Database.

Authors:  Tomonobu Abe; Hiroyuki Yamamoto; Hiroaki Miyata; Noboru Motomura; Yoshiyuki Tokuda; Kazuo Tanemoto; Akihiro Usui; Shinichi Takamoto
Journal:  Eur J Cardiothorac Surg       Date:  2020-04-01       Impact factor: 4.191

8.  Significance of malperfusion syndromes prior to contemporary surgical repair for acute type A dissection: outcomes and need for additional revascularizations.

Authors:  Arnar Geirsson; Wilson Y Szeto; Alberto Pochettino; Michael L McGarvey; Martin G Keane; Y Joseph Woo; John G Augoustides; Joseph E Bavaria
Journal:  Eur J Cardiothorac Surg       Date:  2007-05-17       Impact factor: 4.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.